Unlock instant, AI-driven research and patent intelligence for your innovation.

Pluripotent joint progenitor cells, compositions and methods of making same

A technology of progenitor cells and pluripotency, applied in the field of pluripotent joint progenitor cells, their composition and preparation, can solve the problems of insufficient environmental clues for correct differentiation and repair of cells, and unsatisfactory results

Pending Publication Date: 2022-05-27
THE THIRD HOSPITAL OF HEBEI MEDICAL UNIV +1
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Cell-based therapies, such as joint injections of exogenous stem cells (eg, bone marrow MSCs), have been developed, but results may be suboptimal because environmental cues for cells to undergo proper differentiation and repair are insufficient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pluripotent joint progenitor cells, compositions and methods of making same
  • Pluripotent joint progenitor cells, compositions and methods of making same
  • Pluripotent joint progenitor cells, compositions and methods of making same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0102] Example 1: Lgr5 as a new marker of distinct cells in developing synovial joints

[0103] As interstitial cells are progenitors, we screened these cells with a panel of stem cell markers and examined Lgr5 expression by q-RT-PCR ( Figure 9 ). Using GFP expression in Lgr5-eGFP-IRES-CreERT2 (Lgr5-GFP) mice, we identified Lgr5 as a marker for interstitial cells. Lgr5-GFP is a null allele in which GFP expression replaces Lgr5 (Barker et al., 2007). Heterozygous mice for this allele are normal and viable, whereas homozygous mice die perinatally (Barker et al., 2007). However, we did not observe abnormalities in limb development or synovial joint formation in homozygotes ( Figure 10 ). All analyses of Lgr5 / GFP expression in synovial joints were performed in mice heterozygous for this allele. The finger joints develop from proximal to distal, thereby providing information on progression. By whole-body embryo analysis of Lgr5-GFP mice, we detected GFP in knuckles from E13...

Embodiment 2

[0104] Example 2: Lgr5 expression starts after Gdf5 expression in knuckle formation

[0105] Gdf5 is a marker for interstitial cells (Merino et al., 1999; Storm and Kingsley, 1999). We compared adjacent slices in finger III ( figure 1 Expression of Lgr5 and Gdf5 in c-1f). Gdf5 is already expressed in the P2 / 3 interzone, the last joint formed at E14.5 ( figure 1 c), but not yet expressing Lgr5 ( figure 1 c), which indicates that the latter is expressed later. In the more proximal P1 / P2 and M / P1 joints, both Gdf5 and Lgr5 were expressed. Interestingly, Lgr5 expression was localized to the center-to-edge location of GDF5-expressing compartment cells in each joint ( figure 1 d). At E16.5, just before the formation of the articular cavity, Gdf5 was consistently expressed in the interspace region and exhibited a distinct horseshoe-shaped distribution ( figure 1 e), where Lgr5+ cells are located in the center of the horseshoe ( figure 1 f, circles), flanked by distinct Gdf5+ ...

Embodiment 3

[0106] Example 3: Expression of Lgr5 in the developing knee joint

[0107] The knee joint is more complex due to its additional structures with the meniscus and cruciate ligaments. Whole embryo imaging of E16.5 shows specific Lgr5 expression ( figure 1 g). We examined the periphery of developing joints from E13.5 to E18.5 ( figure 1 i) and central ( figure 1 j) Tissue sections of the area, such as figure 1 shown in h. Lgr5 is expressed in the interspace as early as E13.5, prior to the formation of the meniscus, articular cartilage and cruciate ligament. From E16.5, with early joint cavity formation and formation of the meniscus and cruciate ligaments, to E18.5 joint maturation, Lgr5 expression becomes localized to the future articular surface of the knee joint and attenuates ( figure 1 i; outer slices). However, at this stage, many Lgr5+ cells become evident in the developing lateral and medial menisci ( figure 1 i, outer slice). These Lgr5+ cells are located in the c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

In one embodiment, a method of treatment is provided using a pluripotent joint progenitor cell (JPC), and a method of treatment using a pluripotent joint progenitor cell (JPC) is provided. Also provided are JPC populations, their use in the preparation of medicaments, and methods for their preparation.

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS [0002] This application claims priority to Provisional Patent Application No. 62 / 892,067, filed August 27, 2019, entitled Multipotent Joint Progenitor Cells, Compositions and Methods Thereof, the contents of which are incorporated herein by reference in their entirety. technical field [0003] The present disclosure provides a method of treatment using multipotent joint progenitor cells (JPC). Also provided are JPC, compositions, and methods of using and making JPC. Background technique [0004] The knee joint consists of three main structures, the articular cartilage, the menisci, and the anterior cruciate ligament (ACL). Articular cartilage is composed of deep band chondrocytes and superficial cells that express lubricin to reduce friction and allow for smoother movement. The meniscus is a type of fibrocartilaginous tissue that works to spread our body weight and reduce friction. The ACL provides stability for angulation ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/545A61K35/32A61P19/02C12N5/077C12N5/074
CPCA61P19/02A61K35/28C12N5/0655C12N2501/15C12N2501/727C12N2506/45
Inventor 冯琛陈振胜陈卓荣林欣
Owner THE THIRD HOSPITAL OF HEBEI MEDICAL UNIV
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More